arrow
A

Alberto Dalla Volta

University of Brescia
H指数:14
被引数:690

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world comparative outcomes of first-line immune combinations (ICI–ICI vs ICI–TKI) in metastatic renal cell carcinoma with sarcomatoid features

晚期肉瘤样特征性肾细胞癌中一线免疫联合疗法(ICI–ICI vs ICI–TKI)的实世界比较结果

2026-10-220
OA
Impact of baseline nutritional and inflammatory markers on safety and efficacy of immune checkpoint inhibitors in cancer patients: a retrospective, monocentric study

癌症患者基线营养和炎症标志物对免疫检查点抑制剂安全性和有效性的影响:一项回顾性、单中心研究

2026-04-280
OAAI
Total and Regional Changes in Body Composition in Metastatic Hormone-sensitive Prostate Cancer Patients Randomized to Receive Androgen Deprivation + Enzalutamide ± Zoledronic Acid. The BONENZA Study

转移性激素敏感性前列腺癌患者接受雄激素剥夺+恩扎卢amide±唑来膦酸治疗后的全身及区域性体成分变化。BONENZA研究

2025-06-010
OAAI
Addition of zoledronic acid to enzalutamide and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: the randomized phase II BONENZA trial

唑来膦酸联合恩扎鲁他胺和雄激素剥夺治疗转移性激素敏感性前列腺癌: 随机II期BONENZA试验

2025-05-030
PRE
Total and regional changes in body composition in metastatic hormone-sensitive prostate cancer (mHSPC) patients randomized to receive androgen deprivation plus enzalutamide plus /- zoledronic acid: The BonEnza study

转移性激素敏感性前列腺癌(mHSPC)患者接受雄激素剥夺联合恩扎卢胺联合/不联合唑来膦酸治疗后的全身及区域身体成分变化:BonEnza研究

2024-09-010
PRE
Whole-body Diffusion-weighted Magnetic Resonance Imaging for Assessment of the Bone Response Rate in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Enzalutamide
2024-09-012
OA
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study
2024-04-242
OA
Changes in bone mineral density, trabecular bone score and body composition in metastatic hormone-sensitive prostate cancer (mHSPC) patients randomized to receive androgen deprivation plus enzalutamide plus/minus zoledronic acid: The BonEnza study
2023-10-010
OAAI
Effect of Degarelix Administration on Bone Health in Prostate Cancer Patients Without Bone Metastases. The Blade Study

地加瑞克对无骨转移的前列腺癌患者骨健康的影响。刀片研究

2022-08-1610
OA
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic
2021-10-141
OAAI
Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer patients: A multicentre, randomised Phase III study by the Piemonte Oncology Network
2021-09-015
PRE